NCT04580186 is a clinical trial of bladder exstrophy repair in Bladder Exstrophy, sponsored by Assiut University.

Who is sponsoring NCT04580186?

NCT04580186 is sponsored by Assiut University.

What drugs are being tested in NCT04580186?

Interventions in NCT04580186: bladder exstrophy repair.

What condition does NCT04580186 study?

NCT04580186 studies Bladder Exstrophy.

Is NCT04580186 still recruiting?

NCT04580186 is currently status unknown. Last updated 27 April 2021.

Last reviewed 2021-04-27 · How we verify

NCT04580186

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outcome Of Classic Bladder Exstrophy Repair, Assiut University Experience

Status unknown Last updated 27 April 2021

What this trial tests

trial testing bladder exstrophy repair in Bladder Exstrophy in 10 participants. Status unknown.

Timeline

15 May 2021

Primary endpoint
30 September 2022

30 December 2022

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	10
Start date	15 May 2021
Primary completion	30 September 2022
Estimated completion	30 December 2022

Drugs / interventions tested

bladder exstrophy repair

Conditions studied

Bladder Exstrophy — all drugs for Bladder Exstrophy →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Bladder Exstrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. To review surgical and medical outcomes of the previous repaired bladder exstrophy cases. 2. To present recent developments in surgical techniques and care of these patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04580186 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 27 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04580186.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing